John M. Pinney - Bethesda MD, US Jack E. Henningfield - Baltimore MD, US Saul Shiffman - Pittsburgh PA, US Joseph Gitchell - Bethesda MD, US Edward J. Cone - Severna Park MD, US
Assignee:
JSR, LLC - Bethesda MD
International Classification:
A61F013/00 A61K009/48 A61K009/14 A61K009/20
US Classification:
424434, 424451, 424489, 424464, 424 48, 424484
Abstract:
A two-stage medicine delivery system provides an initial dose of medicine and a second dose of medicine. The initial and second doses are capable of achieving a rapid pharmacological effect and a prolonged pharmacological effect, respectively. The two-stage medicine delivery system preferably delivers a craving reduction substance, in which case, the rapid and prolonged pharmacological effects include a rapid and prolonged craving reduction. Preferably, the delivery system is a nicotine delivery system which is provided in chewing gum form or lozenge form and which provides the nicotine in a transmucosally absorbable form. The two-stage medicine delivery system preferably releases a buffering agent which increases a pH level in a user's mouth to facilitate absorption of the medicine when the delivery system is placed in the user's mouth. A method of making the medicine delivery system also is provided. The system and apparatus can be adapted to reduce cravings for alcohol, food, drugs (e. g.
Tommy L. Chau - Ashburn VA, US John M. Pinney - St. Michaels MD, US Jack E. Henningfield - Baltimore MD, US Edward J. Cone - Severna Park MD, US Saul M. Shiffman - Pittsburgh PA, US Joseph G. Gitchell - Chevy Chase MD, US
Assignee:
JSRNTI, LLC - Bethesda MD
International Classification:
A61K 9/68
US Classification:
424 48
Abstract:
A method is provided of making a medicinal delivery system which satiates a craving in an individual when the medicinal delivery system is administered orally to the individual. A coating composition is applied on a saliva-soluble powder to establish a coated powder, the coating composition featuring an at least partially solubilized craving satiation medicinal compound. The coated powder is combined with an edible carrier base to establish a medicinal delivery system that rapidly releases medicine and buffer preferably followed by slower, sustained release.
Two-Stage Transmucosal Medicine Delivery System For Symptom Relief
JOHN M. PINNEY - BETHESDA MD, US JACK E. HENNINGFIELD - BALTIMORE MD, US SAUL SHIFFMAN - PITTSBURGH PA, US JOSEPH GITCHELL - BETHESDA MD, US EDWARD J. CONE - SEVERNA PARK MD, US
International Classification:
A61F013/00
US Classification:
424/435000, 424/434000
Abstract:
A two-stage medicine delivery system provides an initial dose of medicine and a second dose of medicine. The initial and second doses are capable of achieving a rapid pharmacological effect and a prolonged pharmacological effect, respectively. The two-stage medicine delivery system preferably delivers a craving reduction substance, in which case, the rapid and prolonged pharmacological effects include a rapid and prolonged craving reduction. Preferably, the delivery system is a nicotine delivery system which is provided in chewing gum form or lozenge form and which provides the nicotine in a transmucosally absorbable form. The two-stage medicine delivery system preferably releases a buffering agent which increases a pH level in a user's mouth to facilitate absorption of the medicine when the delivery system is placed in the user's mouth. A method of making the medicine delivery system also is provided. The system and apparatus can be adapted to reduce cravings for alcohol, food, drugs (e.g., cocaine, opiates and the like) and tobacco products, especially tobacco products containing nicotine.
Two-Stage Transmucosal Medicine Delivery System For Symptom Relief
John Pinney - Bethesda MD, US Jack Henningfield - Baltimore MD, US Saul Shiffman - Pittsburgh PA, US Joseph Gitchell - Bethesda MD, US Edward Cone - Severna Park MD, US
International Classification:
A61K031/4439 A61K009/68 A61K009/20
US Classification:
424048000, 424464000, 514343000
Abstract:
A two-stage medicine delivery system provides an initial dose of medicine and a second dose of medicine. The initial and second doses are capable of achieving a rapid pharmacological effect and a prolonged pharmacological effect, respectively. The two-stage medicine delivery system preferably delivers a craving reduction substance, in which case, the rapid and prolonged pharmacological effects include a rapid and prolonged craving reduction. Preferably, the delivery system is a nicotine delivery system which is provided in chewing gum form or lozenge form and which provides the nicotine in a transmucosally absorbable form. The two-stage medicine delivery system preferably releases a buffering agent which increases a pH level in a user's mouth to facilitate absorption of the medicine when the delivery system is placed in the user's mouth. A method of making the medicine delivery system also is provided. The system and apparatus can be adapted to reduce cravings for alcohol, food, drugs (e.g., cocaine, opiates and the like) and tobacco products, especially tobacco products containing nicotine.
- Bethesda MD, US John M. PINNEY - St. Michael's MD, US Jack E. HENNINGFIELD - Baltimore MD, US Edward J. CONE - Severna Park MD, US Saul M. SHIFFMAN - Pittsburgh PA, US Joseph G. GITCHELL - Chevy Chase MD, US
International Classification:
A61K 9/68 A61K 9/00 A61K 31/4406 A61K 31/465
Abstract:
A method is provided of making a medicinal delivery system which satiates a craving in an individual when the medicinal delivery system is administered orally to the individual. A coating composition is applied on a saliva-soluble powder to establish a coated powder, the coating composition featuring an at least partially solubilized craving satiation medicinal compound. The coated powder is combined with an edible carrier base to establish a medicinal delivery system that rapidly releases medicine and buffer preferably followed by slower, sustained release.
- Bethesda MD, US John M. PINNEY - St. Michael's MD, US Jack E. HENNINGFIELD - Baltimore MD, US Edward J. CONE - Severna Park MD, US Saul M. SHIFFMAN - Pittsburgh PA, US Joseph G. GITCHELL - Chevy Chase MD, US
Assignee:
JSRNTI, LLC - Bethesda MD
International Classification:
A61K 9/68 A61K 31/465 A61K 9/00
US Classification:
424440, 514343
Abstract:
A method is provided of making a medicinal delivery system which satiates a craving in an individual when the medicinal delivery system is administered orally to the individual. A coating composition is applied on a saliva-soluble powder to establish a coated powder, the coating composition featuring an at least partially solubilized craving satiation medicinal compound. The coated powder is combined with an edible carrier base to establish a medicinal delivery system that rapidly releases medicine and buffer preferably followed by slower, sustained release.